Outcomes of Clareon PanOptix Pro in Patients With Prior Myopic Refractive Surgery

Part of paid clinical trials in Albuquerque, New Mexico.

Sponsor
Juliette Eye Institute Research Center
Study ID
NCT06555289
Status
Recruiting
Apply to this trial

Conditions

  • Cataract

Eligibility Criteria

Sex
ALL
Age
45 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Clareon PanOptix Pro IOL — DEVICE
    Spherical and toric T3

Study Details

This study is a Single center, single arm, prospective, observational study of clinical outcomes following bilateral cataract surgery and Clareon PanOptix Pro implantation. Subjects will be assessed preoperatively, and at 1 and 3 months postoperatively. Clinical evaluations will include administration of the QUVID and IOLSAT questionnaires, manifest refraction, topography, as well as measurement of visual acuities at distance, intermediate, and near.

Key Dates

Start date
Oct 23, 2024
Status verified
Dec 2025
Primary completion
Sep 1, 2026
Completion
Sep 1, 2026

Study Design

Enrollment
40 participants (estimated)

Primary Outcome Measure

Binocular corrected distance visual acuity (logMAR) [ Time Frame: 3 months postoperative ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Juliette Eye Institute Research CenterAlbuquerqueNew Mexico87113
Zoe Baker, OD
[email protected]
505-355-2020
Robert Melendez, MD, MBA (PRINCIPAL_INVESTIGATOR)

Find similar trials in Albuquerque, NM

By research site
Juliette Eye Institute Research Center· Albuquerque, NM

Related Studies